Search Results - "Eide, I A"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney Transplant by Aasebø, W., Svensson, M., Jenssen, T., Eide, I.A.

    Published in Transplantation proceedings (01-03-2019)
    “…Marine n-3 polyunsaturated fatty acids (PUFAs) may improve cardiovascular, renal, and mental health. No previous trial has investigated the effects of marine…”
    Get full text
    Journal Article
  2. 2

    Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients by Eide, I.A., Rashidi, F., Lønning, K., Oldereid, N.B., Reisæter, A.V., Åsberg, A., Midtvedt, K.

    Published in Transplantation proceedings (01-03-2019)
    “…There are major gaps in the understanding of sexual and reproductive health in female renal transplant recipients. In this Norwegian multicenter retrospective…”
    Get full text
    Journal Article
  3. 3

    Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients by Eide, I A, Dahle, D O, Svensson, M, Hartmann, A, Åsberg, A, Bjerve, K S, Christensen, J H, Schmidt, E B, Lauritsen, M E, Lund, K, Jenssen, T

    Published in European journal of clinical nutrition (01-07-2016)
    “…Background/Objectives: Cardiovascular (CV) disease is the leading cause of death after renal transplantation. Marine n-3 polyunsaturated fatty acids (PUFAs)…”
    Get full text
    Journal Article
  4. 4

    Urinary problems and prostate-specific antigen in a Norwegian normal population by Eide, I A, Angelsen, A, Øverland, G B, Vada, K, Vatten, L

    Published in Tidsskrift for den Norske Lægeforening (20-02-2001)
    “…Measurements of PSA in serum is crucial in the diagnostic work-up of prostatic diseases. We have studied the distribution of PSA values in an unselected…”
    Get full text
    Journal Article
  5. 5

    Prostate-specific antigen by Eide, I A, Angelsen, A

    Published in Tidsskrift for den Norske Lægeforening (10-09-2000)
    “…Serum PSA has been commercially available for more than ten years, and has proved to be the most important tumour marker for prostate cancer. We review the…”
    Get full text
    Journal Article